We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. Bob who wrote (153)6/11/1998 1:57:00 PM
From: Cindy Powell  Read Replies (1) of 196
Greetings Dr. Bob, Kerry and all,

Dr. Bob, yes, I do know a little bit about Lee Kulas' background.

(From SEC filing May 15, 1997)

MDI announced the appointment of Lee F. Kulas as President, Chief Executive Officer and Director.

Mr. Kulas has over 20 years' of broad-based experience in management, marketing, sales and international business development, and has served as chief executive of two medical device start-up companies. He was most recently associated with K. K. Adachi (Osaka, Japan) as president and chief executive officer of Adachi's U.S. operations. Founder and former CEO of Applied Vascular Engineering, Inc. (Nasdaq: AVEI), Kulas has also held marketing and sales positions with the Cordis Corporation (now a division of Johnson & Johnson), Mallinckrodt Interventional Cardiology, the Puritan Bennett Corp. and C.R. Bard.

As an international business development consultant with special
emphasis on Europe and Japan, Kulas spearheaded the establishment of United States operations for two foreign medical products companies. The driving force behind 23 major product introductions, Kulas piloted the "user design team" concept and has supervised clinical research, regulatory submissions and product development activities domestically and in Canada, Europe and Japan. He is named on one patent and two patents pending.

Medical Discoveries is holding it's own! Profit taking has not resulted in as much volatility as I would have expected.
Congratulations to Medical Discoveries and MLSC shareholders! News of these leaps and bounds in progress for Medical Discoveries has been more than exciting! Todays news was particularly tell-tale of good faith in the potential for MDI-P. I look forward to many more happy returns.

Best wishes to all,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext